Susan A. Watson

Preclinical evaluation of an anti-alpha5beta1 integrin antibody as a novel anti-angiogenic agent.

Vanitha Ramakrishnan, Vinay Bhaskar, Debbie A. Law et al. · PubMed · 2006 · 116 citations

Pharmacy, Oncology, Pharmacology +17

An Antiapoptotic Role for Gastrin and the Gastrin/CCK-2 Receptor in Barrett’s Esophagus

Joseph C. Harris, Philip A. Clarke, Altaf Awan et al. · Cancer Research · 2004 · 86 citations

Medicine, Cancer Biology, Oncology +15

Gastrin Enhances the Angiogenic Potential of Endothelial Cells via Modulation of Heparin-Binding Epidermal-Like Growth Factor

Philip A. Clarke, Jacqueline Dickson, Joseph C. Harris et al. · Cancer Research · 2006 · 48 citations

Medicine, Cancer Biology, Oncology +17

Inhibitory Effects of the Gastrin Receptor Antagonist (L-365,260) on Gastrointestinal Tumor Cells

Susan A. Watson, Lindy G. Durrant, Peter Elston et al. · Cancer · 1991 · 38 citations · Full text

Medicine, Oncology, Pharmacology +8

Effect of Z-360, a novel orally active CCK-2/gastrin receptor antagonist on tumor growth in human pancreatic adenocarcinoma cell lines in vivo and mode of action determinations in vitro

Daisuke Kawasaki, Yutaka Emori, Runa Eta et al. · Cancer Chemotherapy and Pharmacology · 2007 · 37 citations

Medicine, Oncology, Pharmacology +9